Innoviva (INVA) Treasury Shares (2010 - 2024)
Innoviva's (INVA) quarterly Treasury Shares came in at $393.8 million in Q1 2024, little changed YoY from $393.8 million in Q2 2023, and little changed on a QoQ basis from $393.8 million in Q4 2023.
Innoviva (INVA) Treasury Shares (2010 - 2024) Analysis & Trends
Innoviva (INVA) has 9 years of Treasury Shares data on file, last reported at $393.8 million in Q1 2024.
- Quarterly Treasury Shares changed 0.0% year-over-year to $393.8 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $393.8 million (changed 0.0% YoY) and the FY2023 annual result came in at $393.8 million, changed 0.0% from the prior year.
- Treasury Shares steadied at $393.8 million in Q1 2024, from $393.8 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $32.0 million in Q2 2021 to a low of $32.0 million in Q2 2021.
- A 4-year average of $32.0 million and a median of $32.0 million in 2021 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 0.0% in 2022, down 0.0% in 2022.
- Tracing INVA's Treasury Shares over 4 years: stood at $393.8 million in 2021, then changed by 0.0% to $393.8 million in 2022, then changed by 0.0% to $393.8 million in 2023, then changed by 0.0% to $393.8 million in 2024.
- The last three Treasury Shares figures came in at $393.8 million (Q1 2024), $393.8 million (Q4 2023), and $393.8 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 393.83 Mn |
| Mar 31, 2024 | 32.01 Mn |
| Mar 31, 2024 | 32.01 Mn |
| Mar 31, 2024 | 393.83 Mn |
| Dec 31, 2023 | 393.83 Mn |
| Dec 31, 2023 | 393.83 Mn |
| Dec 31, 2023 | 32.01 Mn |
| Dec 31, 2023 | 32.01 Mn |
| Sep 30, 2023 | 32.01 Mn |
| Sep 30, 2023 | 393.83 Mn |
| Sep 30, 2023 | 393.83 Mn |
| Sep 30, 2023 | 32.01 Mn |
| Jun 30, 2023 | 393.83 Mn |
| Jun 30, 2023 | 393.83 Mn |
| Jun 30, 2023 | 32.01 Mn |
| Jun 30, 2023 | 32.01 Mn |
| Mar 31, 2023 | 393.83 Mn |
| Mar 31, 2023 | 32.01 Mn |
| Mar 31, 2023 | 393.83 Mn |
| Mar 31, 2023 | 32.01 Mn |